Table 1.
miRNAs potentially involved in PD pathophysiology
miRNA | Target genes | Function | Reference |
---|---|---|---|
miR-7 | SNCA | Downregulate α-synuclein expression in nervous system, protect cells against oxidative stress | 34 |
miR-153 | SNCA | Directly reduce SNCA protein expression. miR-7 and miR-153 are synergistic in their effect | 35 |
let-7 | E2F1a, pdr-1 | Co-underexpress in the alpha-synuclein and pdr-1 strains; influence on pathogenicity of mutant LRRK2 via E2F1 and DP | 48,106 |
miR-184* | DPa | Regulate DAb neurons survival and activity: influence on pathogenicity of mutant LRRK2 via E2F1 and DP | 48 |
miR-34b | Not found | Regulate expression of DJ1 and Parkin, two proteins associated to familial forms of PD | 66 |
miR-34c | Not found | Regulate expression of DJ1 and Parkin, two proteins associated to familial forms of PD | 66 |
miR-133b | Pitx3c | Regulation of maturation and functioning of midbrain dopaminergic neurons within a negative feedback circuit | 69 |
miR-433 | FGF20d | Increase translation of FGF20, which is correlated with increased α-synuclein expression | 83 |
Notes:
E2F1 and DP (transcription factors);
DA (dopaminergic);
Pitx3 (pituitary homeobox 3);
FGF20 (fibroblast growth factor 20).
Abbreviations: DA, dopaminergic; FGF20, fibroblast growth factor 20; LRRK2, leucine-rich repeat kinase 2; Pitx3, pituitary homeobox 3; PD, Parkinson’s disease.